[144] CALIX, INC. SEC Filing
Rhea-AI Filing Summary
Calix, Inc. insider sale notice: This Form 144 shows a proposed sale of 24,000 common shares to be executed through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $1,440,000. The securities were acquired the same day, 09/04/2025, by stock option exercise with cash paid on acquisition. The filer previously sold common shares on 08/28/2025 (126,000 shares, $7,560,000), 08/04/2025 (74,000 shares, $4,218,000), 07/23/2025 (108,000 shares, $6,064,000) and 07/22/2025 (92,000 shares, $5,060,000), as disclosed in the form. The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Substantial insider selling disclosed over recent weeks; planned sale is smaller and stems from option exercise.
The filing reports a proposed sale of 24,000 shares acquired by stock option exercise on 09/04/2025 for cash, valued at $1.44 million. Material context comes from prior disposals: four sales between 07/22/2025 and 08/28/2025 totaling 400,000 shares with gross proceeds of $22,902,000. While the current planned sale is routine following option exercise, the pattern of concentrated dispositions by the same individual over a short period can be relevant to market participants evaluating insider activity and share supply dynamics.
TL;DR: Disclosure complies with Rule 144 format; signer affirms absence of undisclosed material information.
The Form 144 contains the required seller, broker and transaction details: broker identity, method of acquisition